Latest Coley's Toxins Stories
NEW YORK (Reuters) - Coley Pharmaceutical Group Inc. on Tuesday said it is starting an early-stage clinical trial of an experimental drug to treat chronic Hepatitis C virus. Coley expects preliminary data from the Phase Ib study of the drug, Actilon, to be available in the second half of 2006.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.